A new WCRI report explores the impact recent opioid legislation has had on injured worker care.
A new WCRI report explores the impact recent opioid legislation has had on injured worker care.
NKTR-181 (loxicodegol) was to receive an approval decision by August 29th, but a reevaluation of opioid policy has resulted in a delay.
The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.
